Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

282 Views

226. Antimicrobial Novel Agents: Saturday, 12:15 - 1:30 p.m.

Poster Session: Antimicrobial Novel Agents

(2141) Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

TK

Tatsuro Kawamura, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
MO

Masaki Ohuchi, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
TN

Takayuki Nagasawa, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
HO

Hirofumi Ohashi, PhD

Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases
Tokyo, Tokyo, Japan
NI

Naoko Iwata-Yoshikawa, PhD, DVM

Department of Pathology, National Institute of Infectious Diseases
Tokyo, Tokyo, Japan
NS

Nozomi Shiwa-Sudo, PhD, DVM

Department of Pathology, National Institute of Infectious Diseases
Tokyo, Tokyo, Japan
YS

Yusuke Sakai, PhD, DVM

Department of Pathology, National Institute of Infectious Diseases
Kawasaki, Kanagawa, Japan
KM

Katsuma Matsui, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
MM

Masatoshi Matsumoto, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
HK

Haruaki Kurasaki, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
KN

Kazutaka Nagatomo, PhD

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
SI

Shoko Ito, MSc

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
NK

Naoki Kawamura, MSc

PeptiDream Inc.
Kawasaki, Kanagawa, Japan
KM

Keiichi Masuya, PhD

PeptiAID Inc.
Kawasaki, Kanagawa, Japan
NN

Noriyo Nagata, PhD, DVM

Department of Pathology, National Institute of Infectious Diseases
Kawasaki, Kanagawa, Japan
KW

Koichi Watashi, PhD

Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases
Tokyo, Tokyo, Japan
TS

Tadaki Suzuki, MD, PhD

Department of Pathology, National Institute of Infectious Diseases
Tokyo, Tokyo, Japan
HK

Hidetomo Kitamura, PhD, DVM

PeptiDream Inc.
Kawasaki, Kanagawa, Japan

Presenting Author(s)

Masato Murakami, MD, PhD (he/him/his)

CMO
PeptiDream Inc.
Kawasaki-shi, Kanagawa, Japan